0001017491-16-000178.txt : 20160520
0001017491-16-000178.hdr.sgml : 20160520
20160520181840
ACCESSION NUMBER: 0001017491-16-000178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160520
FILED AS OF DATE: 20160520
DATE AS OF CHANGE: 20160520
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: APRICUS BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001017491
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870449967
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11975 EL CAMINO REAL,
STREET 2: SUITE 300
CITY: SAN DIEGO,
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 222-8041
MAIL ADDRESS:
STREET 1: 11975 EL CAMINO REAL,
STREET 2: SUITE 300
CITY: SAN DIEGO,
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: NEXMED INC
DATE OF NAME CHANGE: 19970311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dorsey Brian
CENTRAL INDEX KEY: 0001380762
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22245
FILM NUMBER: 161667495
MAIL ADDRESS:
STREET 1: C/O SOMAXON PHARMACEUTICALS, INC.
STREET 2: 10935 VISTA SORRENTO PARKWAY, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
wf-form4_146378270696341.xml
FORM 4
X0306
4
2016-05-20
0
0001017491
APRICUS BIOSCIENCES, INC.
APRI
0001380762
Dorsey Brian
11975 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
0
1
0
0
SVP, Chief Development Officer
Common Stock
2016-05-20
4
A
0
250000
A
301891
D
Award of 250,000 Restricted Stock Units ("RSUs") under the Issuer's 2012 Stock Long Term Incentive Plan with half of the underlying shares vesting on the Company's receipt of marketing approval of Vitaros in the United States by the Food and Drug Administration on or before December 31, 2018 and the other half of the underlying shares vesting on January 1, 2018, subject to the Reporting Person's continued employment or service to the Issuer through such date.
Not applicable.
/s/ Richard W. Pascoe by power of attorney for Brian Dorsey
2016-05-20